Agarwal Sandeep K
Division of Rheumatology and Clinical Immunogenetics, Department of Internal Medicine, The University of Texas Health Science Center at Houston, 6431 Fannin, MSB 5.270, Houston, Texas 77030, USA.
Discov Med. 2010 Aug;10(51):134-43.
Systemic sclerosis (SSc, scleroderma) is an autoimmune disease clinically characterized by progressive fibrosis in the skin and internal organs. While the pathogenesis of SSc is not completely understood, familial studies and genetic studies suggest that SSc is a complex polygenic disease. In the current review, we will discuss recent studies investigating genetic susceptibility to SSc. Candidate gene studies have identified critical immunoregulatory genes and gene regions including BANK1, FAM167A-BLK, IL23R, IRF5, STAT4, TBX21, and TNFSF4 as susceptibility genes for the development of SSc. More recently a genome-wide association study has been performed and identified CD247 (CD3-zeta) as a novel genetic risk factor for the susceptibility to SSc. Together these genetic association studies have substantially advanced our understanding of SSc pathogenesis and form the foundation for future studies seeking to understand the complexities of SSc.
系统性硬化症(SSc,硬皮病)是一种自身免疫性疾病,临床特征为皮肤和内脏器官进行性纤维化。虽然SSc的发病机制尚未完全明确,但家族研究和基因研究表明,SSc是一种复杂的多基因疾病。在本综述中,我们将讨论近期关于SSc遗传易感性的研究。候选基因研究已确定关键免疫调节基因和基因区域,包括BANK1、FAM167A - BLK、IL23R、IRF5、STAT4、TBX21和TNFSF4作为SSc发病的易感基因。最近进行的一项全基因组关联研究已确定CD247(CD3 - ζ链)是SSc易感性的一种新的遗传风险因素。这些遗传关联研究共同极大地推进了我们对SSc发病机制的理解,并为未来旨在了解SSc复杂性的研究奠定了基础。